Overview
Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist.
Dr. Kalyani is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.
Her clinical research consists of co-authoring 164 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Diabetic Nephropathy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 2, Floor 2, Baltimore, MD 21287
10751 Falls Road, Falls Concourse STE 412, Lutherville, MD 21093
Additional Areas of Focus
Dr. Kalyani has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.
Lancaster General Medical Group
Deepika Pradhan is an Endocrinologist in Lititz, Pennsylvania. Dr. Pradhan is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Diabetic Nephropathy, and Medullary Thyroid Carcinoma.
Charles Rost is an Endocrinologist in Lancaster, Pennsylvania. Dr. Rost is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Diabetic Nephropathy, Anaplastic Thyroid Cancer, Thyroid Cancer, and Follicular Thyroid Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- PancreatectomyDr. Kalyani isDistinguished. Learn about Pancreatectomy.
- Advanced
- Islet Cell TransplantationDr. Kalyani isAdvanced. Learn about Islet Cell Transplantation.
- Maturity Onset Diabetes of the Young
- ObesityDr. Kalyani isAdvanced. Learn about Obesity.
- Seasonal Affective Disorder (SAD)Dr. Kalyani isAdvanced. Learn about Seasonal Affective Disorder (SAD).
- Type 2 Diabetes (T2D)Dr. Kalyani isAdvanced. Learn about Type 2 Diabetes (T2D).
- Vitamin D DeficiencyDr. Kalyani isAdvanced. Learn about Vitamin D Deficiency.
- Experienced
- Abdominal Obesity Metabolic SyndromeDr. Kalyani isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- Diabetic NephropathyDr. Kalyani isExperienced. Learn about Diabetic Nephropathy.
- Exocrine Pancreatic InsufficiencyDr. Kalyani isExperienced. Learn about Exocrine Pancreatic Insufficiency.
- Familial HypertriglyceridemiaDr. Kalyani isExperienced. Learn about Familial Hypertriglyceridemia.
- Low Blood SugarDr. Kalyani isExperienced. Learn about Low Blood Sugar.
- MalnutritionDr. Kalyani isExperienced. Learn about Malnutrition.